Arca
Skip to content

PDE5A: cGMP-specific 3',5'-cyclic phosphodiesterase

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides.

  • Drugs that act on it: 9
  • With a US drug page: 4
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
AvanafilApprovedPhosphodiesterase 5A inhibitorInhibitor—
SildenafilApprovedPhosphodiesterase 5A inhibitorInhibitor—
TadalafilApprovedPhosphodiesterase 5A inhibitorInhibitor—
VardenafilApprovedPhosphodiesterase 5A inhibitorInhibitor—
Gisadenafil—Phosphodiesterase 5A inhibitorInhibitor—
Ibudilast—Phosphodiesterase 5A inhibitorInhibitor—
PF-00489791—Phosphodiesterase 5A inhibitorInhibitor—
PF-03049423—Phosphodiesterase 5A inhibitorInhibitor—
Udenafil—Phosphodiesterase 5A inhibitorInhibitor—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Coronary artery disorder
0.67
Benign prostatic hyperplasia
0.61
Stroke disorder
0.55
Intermittent vascular claudication
0.48
Cardiovascular disorder
0.47
Hypertensive disorder
0.47
Lower urinary tract symptom
0.39

Genes and Related Targets

Complexes and families that share a gene with this target
Genes
PDE5A

Drugs and mechanisms are from ChEMBL CHEMBL1827 (CC BY-SA 3.0). Gene name, function (UniProt O76074, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.